Dr. Thomas Martin, MD
Claim this profileUniversity of California, San Francisco
Studies Multiple Myeloma
Studies Relapse
7 reported clinical trials
14 drugs studied
Affiliated Hospitals
Clinical Trials Thomas Martin, MD is currently running
Talquetamab + Iberdomide + Dexamethasone
for Multiple Myeloma
This phase I trial will evaluate the safety, side effects, and best dose of talquetamab in combination with iberdomide and dexamethasone in treating patients with multiple myeloma that has come back after a period of improvement (relapsed) or has not responded to previous treatment (refractory). There is currently a significant unmet need for patients with relapsed or refractory multiple myeloma (RRMM) who are triple class refractory and have been exposed to B-cell maturation antibody (BCMA) targeted therapy. These patients currently have limited treatment options and poor survival. Talquetamab is an FDA approved drug that can bring T-cells to the myeloma cell, resulting in myeloma cell death. Iberdomide is an investigational drug and works by targeting and destroying proteins that help myeloma cancer cells to survive. Dexamethasone is a corticosteroid, is similar to a natural hormone produced by the adrenal glands to reduce inflammation (swelling, heat, redness, and pain) and is used to in helping to treat certain types of cancer including myeloma.
Recruiting1 award Phase 1
Cord Blood Units
for Blood Cancers
This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.
Recruiting1 award N/A3 criteria
More about Thomas Martin, MD
Clinical Trial Related1 year of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Thomas Martin, MD has experience with
- Dexamethasone
- Bone Marrow Biopsy
- Talquetamab
- Cyclophosphamide
- Fludarabine
- Manufactured Anti-BCMA CAR-T Cells
Breakdown of trials Thomas Martin, MD has run
Multiple Myeloma
Relapse
Cancer
Mixed-Cell Lymphoma
Childhood Blood Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Thomas Martin, MD specialize in?
Thomas Martin, MD focuses on Multiple Myeloma and Relapse. In particular, much of their work with Multiple Myeloma has involved Stage IV patients, or patients who are undergoing treatment.
Is Thomas Martin, MD currently recruiting for clinical trials?
Yes, Thomas Martin, MD is currently recruiting for 2 clinical trials in San Francisco California. If you're interested in participating, you should apply.
Are there any treatments that Thomas Martin, MD has studied deeply?
Yes, Thomas Martin, MD has studied treatments such as Dexamethasone, Bone Marrow Biopsy, Talquetamab.
What is the best way to schedule an appointment with Thomas Martin, MD?
Apply for one of the trials that Thomas Martin, MD is conducting.
What is the office address of Thomas Martin, MD?
The office of Thomas Martin, MD is located at: University of California, San Francisco, San Francisco, California 94143 United States. This is the address for their practice at the University of California, San Francisco.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.